All nine Fine Fettle cannabis dispensaries in Connecticut transition to hybrid operations starting Thursday, accommodating both medical patients and adult-use customers. This shift follows state regulatory updates permitting recreational retailers to serve registered medical marijuana patients. The move arrives amid a 1.2 percent dip in total cannabis sales to $290 million in 2025, even as product units rose 11.8 percent.
Regulatory Changes Open Doors for Hybrids
Connecticut recently amended its cannabis rules to let adult-use dispensaries function as hybrids. Previously, some locations like Fine Fettle's in Manchester, Norwalk, Old Saybrook, Waterbury, and West Hartford served only recreational buyers. The company's four other sites already operated in hybrid mode, but full conversion now unifies services statewide.
Connecticut's Evolving Cannabis Market
Medical marijuana sales dropped 22.6 percent to $72.5 million in 2025 from $93.6 million the prior year, while adult-use sales climbed 8.8 percent to $217.5 million. Medical products now claim 25 percent of the market, down from 32 percent. Patients register with physician certification, face lower taxes, gain pharmacist consultations, and buy larger amounts than recreational users.
Addressing Access Gaps for Patients
Benjamin Zachs, Fine Fettle's chief operating officer, emphasized regional access issues. “Patients shouldn’t have to travel far for care or be stuck with limited options,” he said. “With this model, we can responsibly serve both patients and customers while keeping Connecticut’s medical community strong.” Fine Fettle runs dispensaries in Connecticut, Massachusetts, and Georgia, positioning the chain to capture shifting demand.
